EN ZH-CN ZH-TW JA FR NL ES DE PT

News

GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center

April 9, 2019 - Osaka, Japan - Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that GeneDesign, Inc. has joined the global organization.…

News Archive

GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center

Read Article

Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services’ Global Leadership Team as Vice President of Sales and Marketing

Read Article

Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth

Read Article

Ajinomoto and XL-protein forge Strategic Alliance to develop PASylated therapeutics applying the Corynex® platform

Read Article

Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing

Read Article

Precision NanoSystems Announces Manufacturing Collaboration Agreement with Ajinomoto Bio-Pharma Services for GMP Manufacturing of High Quality Nanomedicines

Read Article

Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry

Read Article

Ajinomoto Althea, Inc. Announces Additions to Management Team as it transforms into a global CDMO

Read Article

The Government of Flanders recently agreed to participate in Ajinomoto OmniChem’s investments into new and innovative technologies.

Read Article

On the 22nd September 2017 Granules OmniChem Limited (GOC) received the Establishment Inspection Report (EIR) from the US-FDA

Read Article

Louvain-la-Neuve: New address from 01/10/2017

Read Article

Ajinomoto Althea, Inc. Opens Manufacturing Suites in New High Potency and Antibody Drug Conjugate Commercial Facility

Read Article

Ajinomoto Althea, Inc. Announces New Aseptic Fill Finish Line

Read Article

CEO J. David Enloe Awarded 'Most Admired CEO'

Read Article

Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing

Read Article

Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing

Read Article

Ajinomoto Group Acquires All Shares of GeneDesign, a Nucleic Acid Drug CDMO, to Accelerate Expansion of the Contract Business for Oligonucleotides.

Read Article

Biologics candidate manufactured using Ajinomoto Co., Inc.’s CORYNEX® Protein Expression System enters clinical trials for the first time

Read Article

Ajinomoto Althea, Inc. Announces Issuance of New US Patent for Manufacturing of Crystal Monoclonal Antibodies

Read Article

Ajinomoto Althea, Inc. Expands Its Capacity of Fill Finish Manufacturing with Addition of Second Shift

Read Article

Ajinomoto Althea, Inc. Launches Process and Analytical Development Services for Antibody Drug Conjugates (ADCs) Therapeutics

Read Article

Ajinomoto Althea, Inc. Expands Manufacturing Capabilities to ADC Fill Finish and Bioconjugation

Read Article

Ajinomoto Althea, Inc. Awarded CA Tax Credit

Read Article

Ajinomoto Althea, Inc. Receives European GMP Certification for Commercial Aseptic Filling and Testing

Read Article

Althea’s New Drug Formulation Technology Gains Attention from Two More Top Pharmaceutical Companies

Read Article

Ajinomoto Althea, Inc. Receives European GMP Certification

Read Article

Ajinomoto Althea Inc. Now Offering A Novel Protein Production Platform: Corynex®

Read Article

Ajinomoto Althea Inc. Appoints J. David Enloe as President and Chief Executive Officer

Read Article

Ajinomoto Althea, Inc. Selected as a Finalist in 26th Annual CONNECT Most Innovative New Product Awards

Read Article

Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc

Read Article

Ajinomoto Co., Inc. Agrees to Acquire Althea Technologies, Inc.

Read Article

Althea Technologies & Profectus Biosciences Sign Manufacturing Agreement for Plasmid DNA Production

Read Article

Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen

Read Article

Althea Technologies Announces Expanded Roles for Key Executives

Read Article